Search Results
Found 59 results for label/Opini.
Major Clinical Trial Reforms Underway in China’s Regulatory Environment
Bill Wang, director of regulatory affairs, discusses China’s regulatory environment in the second-largest pharmaceutical market in the world.
Who We Are
Our Mission We know that patients – people the world over, our family, our neighbors, ourselves – are depending on…
Women’s Health Clinical Trials and Research
Our experience in conducting Phase I-IV and consumer health women’s health studies includes thousands of patients and hundreds of sites.
Early Engagement Strategies to Set Cell & Gene Therapies Up for Success
Understand the key elements drug developers need to focus on in the early stages of their cell and gene therapy program that will set them up for future success.
Time to Act is Now: Paediatrics Medicines Development in the UK
Pediatric applications will be regulated in the U.K. by the Medicines Healthcare and Regulatory Agency (MHRA) beginning 1 January 2021. If you have not acted yet, the time is now.
Decentralized Clinical Trial Resources
Check out PPD Digital’s extensive library of materials on decentralized clinical trials (DCTs).
Choosing DCTs
Decentralized Clinical Trials present opportunities to emphasize clinical trial convenience, safety, and flexibility.
Prepare Now for EU Clinical Trial Regulation Go-Live Date
PPD’s cross-functional EU clinical trial regulation (CTR) readiness team continues to keep a close eye on the new EU CTR and its potential impacts, working to embrace this change and to ensure sponsors are ready from day one.
Rare Metabolic Disease
Rare metabolic disorder clinical research solutions from PPD come with years of endocrine specific experience for your trial.